))
Dermatology Edition: Top Headlines for Week of September 18, 2023
Manage episode 407442256 series 3560281
Sisällön tarjoaa Healio. Healio tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In this edition, CDC issues a health advisory concerning flesh-eating bacterium, staging for melanoma does not represent accurate recurrence and mortality and more. Read the full coverage here:
CDC issues health advisory about recent reports of fatal Vibrio vulnificus
Study finds melanoma treatment costs have increased, but so has survival
Melanoma staging system inaccurately reflects recurrence, mortality risk
Study: Nemolizumab shows promise as prurigo nodularis treatment
Adverse events after ICI treatment linked to improved outcomes in patients with melanoma
References:
Bateni SB, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3179.
Deng J, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.2609.
Du Y, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3003.
Helvind NM, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3256.
107 jaksoa
Jaa
